Stockreport

IMUNON stock rallies 19% on early results for COVID-19 vaccine [Seeking Alpha]

Imunon, Inc.  (IMNN) 
PDF The lab, Wistar Institute, conducted the challenge against the SARS-CoV-2 variant XBB.1.5, which health officials consider a variant of concern. The study utilized a cl [Read more]